Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 3418 | 1913 | 30.3 | 63% |
Classes in level above (level 2) |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | LIVE ATTENUATED INFLUENZA VACCINE | Author keyword | 39 | 55% | 3% | 48 |
| 2 | INFLUENZA VACCINE | Author keyword | 25 | 16% | 8% | 147 |
| 3 | INFLUENZA | Address | 24 | 13% | 9% | 174 |
| 4 | TRIVALENT INACTIVATED INFLUENZA VACCINE | Author keyword | 22 | 66% | 1% | 21 |
| 5 | VACCINE EFFECTIVENESS | Author keyword | 20 | 26% | 4% | 68 |
| 6 | INFLUENZA VACCINES | Author keyword | 18 | 24% | 3% | 65 |
| 7 | INFLUENZA AND OTHER RESPIRATORY VIRUSES | Journal | 12 | 12% | 5% | 92 |
| 8 | INFLUENZA VACCINE EFFECTIVENESS | Author keyword | 11 | 67% | 1% | 10 |
| 9 | TRIVALENT INFLUENZA VACCINE | Author keyword | 9 | 50% | 1% | 13 |
| 10 | INFECT DIS PREVENT CONTROL BRANCH | Address | 9 | 83% | 0% | 5 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | LABORATORY CONFIRMED INFLUENZA | 90 | 83% | 3% | 50 |
| 2 | OUTPATIENT VISITS | 66 | 60% | 4% | 72 |
| 3 | TEST NEGATIVE DESIGN | 47 | 84% | 1% | 26 |
| 4 | SEASONAL INFLUENZA | 47 | 24% | 9% | 169 |
| 5 | CULTURE CONFIRMED INFLUENZA | 37 | 64% | 2% | 36 |
| 6 | HOSPITALIZATIONS | 26 | 12% | 11% | 204 |
| 7 | TRIVALENT | 25 | 18% | 7% | 125 |
| 8 | ADVISORY COMMITTEE | 14 | 14% | 5% | 93 |
| 9 | IMMUNIZATION PRACTICES ACIP | 12 | 14% | 4% | 81 |
| 10 | VIRUS VACCINE | 11 | 13% | 4% | 84 |
Journals |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | INFLUENZA AND OTHER RESPIRATORY VIRUSES | 12 | 12% | 5% | 92 |
Reviews |
| Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
|---|---|---|---|---|
| Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis | 2012 | 377 | 50 | 70% |
| Comparing influenza vaccine efficacy against mismatched and matched strains: a systematic review and meta-analysis | 2013 | 41 | 45 | 44% |
| Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis | 2011 | 99 | 76 | 39% |
| The relative efficacy of trivalent live attenuated and inactivated influenza vaccines in children and adults | 2011 | 50 | 30 | 63% |
| The Burden of Influenza B: A Structured Literature Review | 2013 | 30 | 92 | 43% |
| Seasonal influenza vaccine efficacy and its determinants in children and non-elderly adults: A systematic review with meta-analyses of controlled trials | 2012 | 31 | 45 | 58% |
| Influenza cost and cost-effectiveness studies globally - A review | 2013 | 8 | 11 | 91% |
| Current experience with school-located influenza vaccination programs in the United States A review of the medical literature | 2011 | 17 | 18 | 94% |
| Duration of protection provided by live attenuated influenza vaccine in children | 2008 | 34 | 13 | 85% |
| Vaccines for preventing influenza in healthy children | 2008 | 77 | 92 | 45% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | INFLUENZA | 24 | 13% | 9.1% | 174 |
| 2 | INFECT DIS PREVENT CONTROL BRANCH | 9 | 83% | 0.3% | 5 |
| 3 | PEDIAT INFECT DIS ALLERGY RHEUMATOL | 6 | 80% | 0.2% | 4 |
| 4 | INFLUENZA PROGRAM | 6 | 44% | 0.6% | 11 |
| 5 | EA7310 | 4 | 75% | 0.2% | 3 |
| 6 | SHADYSIDE FAMILY HLTH | 4 | 75% | 0.2% | 3 |
| 7 | VACCINE ACCESS DELIVERY GLOBAL PROGRAM | 4 | 75% | 0.2% | 3 |
| 8 | MODELLING PROJECT SECT | 4 | 56% | 0.3% | 5 |
| 9 | DIRECC GEN SANIDAD CONSUMO | 3 | 100% | 0.2% | 3 |
| 10 | SECRETARIA GEN SALUD PUBL PARTICIPAC | 3 | 50% | 0.2% | 4 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000249346 | INFLUENZA VACCINATION//INFLUENZA VACCINE//HEALTH CARE WORKERS |
| 2 | 0.0000227823 | LIVE ATTENUATED INFLUENZA VACCINE//LAIV//OCULO RESPIRATORY SYNDROME |
| 3 | 0.0000205093 | H1N1//INFLUENZA A H1N1//H1N1 SUBTYPE |
| 4 | 0.0000186591 | PANDEMIC//SCHOOL CLOSURE//PANDEMIC INFLUENZA |
| 5 | 0.0000153174 | RAPID INFLUENZA DIAGNOSTIC TEST//RESPIRATORY VIRUSES//RAPID ANTIGEN TEST |
| 6 | 0.0000120701 | AS03//UNIVERSAL VACCINE//HETEROSUBTYPIC IMMUNITY |
| 7 | 0.0000100983 | ATHEROSCLEROSIS LIPID DISORDERS//PANDEMIC 2009 H1N1//PRIMARY CARE SERV TARRAGONA |
| 8 | 0.0000093341 | RICHARD K MELLON FDN//SECONDARY BACTERIAL PNEUMONIA//INFECTION HISTORY |
| 9 | 0.0000086854 | HEMAGGLUTININ//ANTIGENIC DRIFT//D222G |
| 10 | 0.0000084058 | SYNDROMIC SURVEILLANCE//OUTBREAK DETECTION//RODS |